Dr. Jay S. Skyler
Board Member
SAB Biotherapeutics, Inc. (SABS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Jay S. Skyler
Dr. Jay S. Skyler is recorded as Board Member at SAB Biotherapeutics, Inc. (SABS). SAB Biotherapeutics, Inc. reported in an 8-K filed May 8, 2024 that Dr. Jay S. Skyler was appointed Class I director, effective May 3, 2024.
“On May 3, 2024, the Nominating and Corporate Governance Committee (the "Committee") of the Board of Directors (the "Board") of SAB Biotherapeutics, Inc., a Delaware corporation (the "Company"), recommended the appointment of, and the Board subsequently appointed, Dr. Jay S. Skyler to serve as a Class I director of the Company, effective as of May 3, 2024, and to serve until the Company's 2025 annual meeting of stockholders or until Dr. Skyler's successor is duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at SAB Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Samuel J. Reich CEO, Board Member
- David Zaccardelli Chairman, Board Member
- Lucy To CFO
- Mark Conley CFO
- Michael King CFO
- Christoph Bausch COO
- Andrew D. Moin Board Member
- Andrew Moin Board Member
- David Link Board Member
- Eddie J. Sullivan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.